We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Lynx to Perform Study for Genome Institute of Singapore

By Biotechdaily staff writers
Posted on 18 Mar 2003
An agreement to conduct a comparative transcriptome study for the Genome Institute of Singapore at the National University of Singapore (GIS) has been announced by Lynx Therapeutics, Inc. More...
(Hayward, CA, USA).

Lynx will use its massively parallel signature sequencing (MPSS) technology to generate comprehensive gene expression profiles from matched samples of human, mouse, and fish tissues. GIS will pay Lynx for the genomics discovery services performed on the GIS samples. Following a successful outcome, GIS and Lynx expect to have a broader relationship and to couple the biologic expertise of GIS with the transcriptome profiling ability of Lynx' MPSS.

"We believe that this agreement between Lynx and GIS is an example of combining a powerful technology with broad biologic interests,” said Dr. Edison Liu, executive director of GIS. "By integrating MPSS with other technologies established in GIS, we intend to characterize transcriptomes in depth, annotate genomes with greater precision, and discover genes with practical implementation.”






Related Links:
Genome Institute of Singapore
Lynx

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
HPV Test
Allplex HPV28 Detection
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.